News

SandboxAQ Launches Molecular Simulation Division

June 23, 2023

Sandbox AQ’s molecular simulation division is collaborating with companies like AstraZeneca and Sanofi to develop novel treatments for various disorders.

FDA Releases Draft Guidance for Section 505G of Food, Drug, and Cosmetic Act

June 23, 2023

The guidance describes the CDER formal dispute resolution (FDR) procedures for eligible requestors or sponsors that wish to appeal a scientific and/or medical issue related to a final order.

Andelyn Biosciences Opens New CGT Manufacturing Headquarters

June 22, 2023

The new headquarters located in Columbus, Ohio, more than triples Andelyn Biosciences’ footprint to meet growing demand for CGT services.

FDA Releases Updated COVID-19 Vaccine Guidelines

June 21, 2023

The new guidelines contain formulation recommendations for vaccines launching in autumn 2023.

FDA Launches Pilot Program Using Cancer Biomarkers to Mitigate Risk

June 21, 2023

FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.

Saudi Arabia’ PIF Launches Lifera, a New CDMO

June 21, 2023

PIF has established Lifera, a new manufacturing entity that will manufacture, stockpile, and supply bio/pharmaceuticals both locally and through partnerships.

Enzene Biosciences Invests $50 Million into New Jersey Biomanufacturing Facility

June 21, 2023

India’s Enzene Biosciences is investing $50 Million into a new biopharma manufacturing plant in Hopewell, NJ.

Eli Lilly Set to Acquire DICE Therapeutics

June 20, 2023

The transaction is expected to close in the third quarter of 2023.

University of Waterloo Researchers Announce Sustainable Encapsulation Technology

June 20, 2023

Researchers at the University of Waterloo have developed a liquid-liquid encapsulation system for use in sustainable encapsulation processes.

Lilly Enters Gene Editing Collaboration with Verve Therapeutics

June 20, 2023

Eli Lilly & Company will pay Verve Therapeutics up to $525 million to advance a lipoprotein gene editing research program.